Friday, February 01, 2008

Friday Roundup

The CyclingNews contains in depth interviews with Johan Bruyneel, who will discuss Astana and doping in Part II, and Bob Stapleton of Team High Road. Stapleton discusses T-Mobiles dubious history of doping infractions, the implementation of ACE program, and the new UCI "bio passports".

The CyclingNews Letters column overflows this week with topics ranging from the UCI vs well, everyone, to Floyd Landis' participation in the NUE series. Landis gets two nice letters of support for his intention to ride in the MTB endurance events this year.

Rant read what Steve Johnson, CEO of USAC. had to say about eliminating "undesirable" cyclists from this year's Tour of California. Rant also posts the rules that govern what information about any rider can be shared and how it is to be disseminated. Rant has a message for Mr. Johnson:

Since you’ve stated that unless someone tells you it’s against the rules, you’ll be informing AEG about the status of any ongoing investigations regarding proposed riders for the upcoming Tour of California, I’m here to tell you: It’s against the rules. You can’t share that information.

Followup above. He thinks rider contracts let him do what he wants.

Inside Bureaucracy's Calvini works a Landis reference into an article about rural power needs.

SteroidReport, new to us (we think), finds some interesting articles. Among them is one suggesting that HgH may help aid recovery from the concussions common in football. Our current moralistic position seems to be that it's OK for players to beat their brains out, but unfair for them to try to heal them.

And we get a link, so thanks!


Anonymous said...

I've been a fan of TBV for some time. Good info and good commentary.

Yes, the therapeutic uses of testosterone and growth hormone complicate the doping picture.

This is especially true when the actual sports is what causes the need for medically-indicated (therapeutic) need for testosterone and/or growth hormone.

It is well established that volume training typical in elite endurance athletes causes significant (statistically and clinically) suppression of testosterone levels.

So, if cycling and/or running causes low testosterone levesl, does that mean that the therapeutic use of exogenous testosterone should be medically indicated (and therefore permitted)??

Therapeutic use of PEDs are problematic for the whole drug testing game.